JOURNAL OF THE CZECH PHARMACEUTICAL SOCIETY AND THE SLOVAK PHARMACEUTICAL SOCIETY

Čes. slov. farm. 2026, 75(2):83-86 | DOI: 10.36290/csf.2026.015

Seasonal allergic rhinitis: an overview of treatment

Jitka Poláková
Ústav imunologie a alergologie, Fakultní nemocnice Plzeň

Seasonal allergic rhinitis (SAR) is a common chronic inflammatory disease of the nasal mucosa that significantly affects patients' quality of life and represents a risk factor for the development of asthma. The pharmacy is often the patient's first point of contact with the healthcare system, placing the pharmacist in a key role in the early identification of the disease, recommending appropriate self-medication, and recognizing situations requiring medical evaluation. This article summarizes current recommendations for the treatment of seasonal allergic rhinitis, focusing on a rational stepwise approach to self-medication in the pharmacy, and provides practical guidelines for pharmaceutical practice.

Keywords: seasonal allergic rhinitis, self-medication, antihistamines, intranasal corticosteroids.

Accepted: May 27, 2026; Published: June 10, 2026  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Poláková J. Seasonal allergic rhinitis: an overview of treatment. Čes. slov. farm. 2026;75(2):83-86. doi: 10.36290/csf.2026.015.
Download citation

References

  1. Brożek JL, et al. Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines-2016 revision. J Allergy Clin Immunol. [Internet] 2017 Oct;140(4):950-958. Available from: doi: 10.1016/j.jaci.2017.03.050 Go to original source... Go to PubMed...
  2. Bousquet J, et al. Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines. Allergy. 2008;63(Suppl 86):8-160. Go to original source...
  3. Seberová E. Alergická rýma, 2. vydání. Maxdorf. 2017.
  4. Vieira RJ, Sousa-Pinto B, Bousquet J, et al. Allergic Rhinitis and Its Impact on Asthma (ARIA)-EAACI Guidelines - 2024-2025 Revision: Part II - Guidelines on Oral and Ocular Treatments. Allergy [Internet]. 2026;1-24 [cited 2026 Mar 31]. Available from: https://doi.org/10.1111/all.70305. Go to original source... Go to PubMed...
  5. Hloch K, Doseděl M. Alergická rýma - jak může pomoci lékárník? Prakt. lékáren. 2017;13(1): 30-35. Go to original source...
  6. Databáze léků [Internet]. SÚKL Praha. [cited 2026 May 19]. Available from: http://www.sukl.cz
  7. Klimek L, Mullol J, Ellis AK, et al. Current Management of Allergic Rhinitis. J Allergy Clin Immunol Pract. 2024;12(6):1399-1412. Go to original source...
  8. Scadding GK, et al. Optimal management of allergic rhinitis. Arch Dis Child. [Internet]. 2015;100(6). [cited 2026 Mar 31] Available from: doi: 10.1136/archdischild-2014-306300. Go to original source... Go to PubMed...
  9. Seberová E. ARIA 2019: Doporučení péče o pacienty s alergickou rýmou v České republice. [Internet]. [cited 2026 Mar 31] Available from https://www.csaki.cz/soubory/stanoviska-a-doporuceni/10.-Alergicka-ryma.pdf.
  10. Seberová E. Alergická rýma z pohledu alergologa. Klin Farmakol Farm. 2026;40(1):13-18. Go to original source...
  11. Euforea pocket guide [Internet]. [cited 2026 Mar 31] Available from: https://s3.nl-ams.scw.cloud/euforea-wp-production/uploads/AR-Pocket-Guide_English.pdf.
  12. Petrů V. Novinky v alergenové imunoterapii. Interní Med. 2017;19(2):78-81. Go to original source...
  13. Nevrlka J. Alergenová imunoterapie inhalačních alergií. Klin Farmakol Farm. 2026;40(1):19-24. Go to original source...
  14. Pfaar O, Sousa-Pinto B, Papadopoulos NG, et al. Digitally-enabled, person-centred care (PCC) in allergen immunotherapy: An ARIA-EAACI Position Paper. Allergy. [Internet]. 2024;79. [cited 2026 Mar 31] Available from: doi:10.1111/all.16135. Go to original source... Go to PubMed...




Czech and Slovak Pharmacy

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.